It is a good question. No I don’t think that NGIO has missed the boat. I think that any government help like BARDA is a very long shot at this time period. There are still private/public endowments that may take a chance with a contribution. But as for the Complete Vaccine, it will probably have to take the standard train of IND, Phases 1, 2, 3 and finally NDA. However, as I previously stated, any derailment of the mRNA, could Warp Speed the Ii-Key process. Meanwhile, NGIO has lots of other irons in the fire that will probably produce revenue faster.
I plan on riding the NGIO train to either glorious success or complete oblivion.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links